These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7931465)

  • 21. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ; Kanellakis P; Bobik A
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery.
    Um JW; Kim JM; Min BW; Kim YS; Son GS; Lee JB; Jung SI; Kim SJ; Choi SY; Koo BH; Ishibashi N; Shirouzu K; Whang CW
    Kurume Med J; 2004; 51(3-4):235-43. PubMed ID: 15682830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
    Gibbons GH
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
    McInnes GT
    J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor.
    Teng J; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Tahira Y; Kanmatsuse K
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.
    Hollenberg NK; Fisher ND; Price DA
    Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibitors and vascular protection in hypertension.
    Ruschitzka F; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S3-12. PubMed ID: 10499558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ACE inhibition on the heart.
    Gavras I; Manolis A; Gavras H
    J Hum Hypertens; 1995 Jun; 9(6):455-8. PubMed ID: 7473527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Okigaki M; Iwasaka T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():139-43. PubMed ID: 15171357
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
    Mombouli JV
    Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of protective effects of ACE inhibition on coronary artery disease.
    Dzau VJ
    Eur Heart J; 1998 Sep; 19 Suppl J():J2-6. PubMed ID: 9796834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
    Lüscher TF; Yang Z
    Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
    Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
    Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.